Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score54
United States Fiscal year ends December CIK 0001658247 Results filed 3 Aug 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Jeff E. Knight
8 Apr 2026
Chief Dev. & Operating Officer
Sold after exercise
85,163
$40.10
$3.42M
Isabel Kalofonos
5 Jan 2026
Chief Commercial Officer
Sold after exercise
2,500
$55.00
$137.50K
Dana Pizzuti
1 Dec 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$45.02
$225.10K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 3
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 4,245,150
History held since 20 Jul 2018